Literature DB >> 7734978

Progress in the drug management of allergic rhinitis.

N Mygind1.   

Abstract

The diagnosis of allergic rhinitis is based on the case history, rhinoscopy and allergy testing. Therapy consists of allergen avoidance, pharmacotherapy, immunotherapy and/or surgery. This review deals only with pharmacotherapy, since there has been significant progress in this area. The first advance was the introduction of topical nasal steroids in the mid-1970s and the second the introduction of the second generation of H1 antihistamines in the early 1980s. The task for future developments is to optimize therapy by rational and combined use of available drugs, especially the steroid sprays and non-sedating antihistamines. A systematic approach to the choice of drug for the treatment of rhinitis is presented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734978     DOI: 10.1007/bf02484439

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Intranasal ipratropium: a new treatment for perennial rhinitis.

Authors:  P Borum; N Mygind; F Schultz Larsen
Journal:  Clin Otolaryngol Allied Sci       Date:  1979-12

2.  The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application.

Authors:  N Lindqvist; M Andersson; M Bende; S Löth; U Pipkorn
Journal:  Clin Exp Allergy       Date:  1989-01       Impact factor: 5.018

3.  Understanding consequences of concurrent therapies.

Authors:  C C Peck; R Temple; J M Collins
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

Review 4.  Glucocorticosteroids and rhinitis.

Authors:  N Mygind
Journal:  Allergy       Date:  1993-10       Impact factor: 13.146

5.  Lack of effect on nasal discharge from a vasoconstrictor spray in common cold.

Authors:  B Winther; S Brofeldt; P Borum; M Pedersen; N Mygind
Journal:  Eur J Respir Dis Suppl       Date:  1983

6.  Nasal septal perforation associated with topical corticosteroid therapy.

Authors:  M L Soderberg-Warner
Journal:  J Pediatr       Date:  1984-11       Impact factor: 4.406

7.  Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis.

Authors:  J A Wihl; B N Petersen; L N Petersen; G Gundersen; K Bresson; N Mygind
Journal:  J Allergy Clin Immunol       Date:  1985-06       Impact factor: 10.793

8.  Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis.

Authors:  B Pedersen; B Bundgaard Larsen; R Dahl; N Lindqvist; N Mygind
Journal:  Allergy       Date:  1991-11       Impact factor: 13.146

9.  Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations.

Authors:  C Secher; J Kirkegaard; P Borum; A Maansson; P Osterhammel; N Mygind
Journal:  J Allergy Clin Immunol       Date:  1982-09       Impact factor: 10.793

10.  Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.

Authors:  V H Balle; U Pedersen; B Engby
Journal:  Rhinology       Date:  1980-09       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.